Rigel Pharmaceuticals (RIGL) Work In Process (2018 - 2026)

Rigel Pharmaceuticals' Work In Process history runs 9 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• In Q1 2026, Work In Process rose 462.69% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $6.2 million (up 462.69% YoY), while the FY2025 annual figure was $3.9 million, up 218.92% from the prior year.
• Work In Process was $6.2 million for Q1 2026 at Rigel Pharmaceuticals, up from $3.9 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $6.2 million in Q1 2026 to a low of $572000.0 in Q2 2022.
• Historically, Work In Process has averaged $2.8 million across 5 years, with a median of $2.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Work In Process surged 1541.36% in 2022, then sank 78.38% in 2025.
• A 5-year view of Work In Process shows it stood at $2.7 million in 2022, then declined by 29.45% to $1.9 million in 2023, then sank by 34.65% to $1.2 million in 2024, then jumped by 218.92% to $3.9 million in 2025, then surged by 59.31% to $6.2 million in 2026.
• The last three Work In Process figures came in at $6.2 million (Q1 2026), $3.9 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.